Cargando…

Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage

This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Edueng, Khadijah, Mahlin, Denny, Gråsjö, Johan, Nylander, Olivia, Thakrani, Manish, Bergström, Christel A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696415/
https://www.ncbi.nlm.nih.gov/pubmed/31357587
http://dx.doi.org/10.3390/molecules24152731
_version_ 1783444265131573248
author Edueng, Khadijah
Mahlin, Denny
Gråsjö, Johan
Nylander, Olivia
Thakrani, Manish
Bergström, Christel A.S.
author_facet Edueng, Khadijah
Mahlin, Denny
Gråsjö, Johan
Nylander, Olivia
Thakrani, Manish
Bergström, Christel A.S.
author_sort Edueng, Khadijah
collection PubMed
description This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoconazole, and sulfathiazole were used as model APIs. The parameters used to assess the supersaturation potential and crystallization kinetics were the maximum supersaturation concentration (C(max,app)), the area under the curve (AUC), and the crystallization rate constant (k). These were compared for freshly spray-dried and aged/crystallized samples. Aged samples were stored at 75% relative humidity for 168 days (6 months) or until they were completely crystallized, whichever came first. The solid-state changes were monitored with differential scanning calorimetry, Raman spectroscopy, and powder X-ray diffraction. Supersaturation potential and crystallization kinetics were investigated using a tenfold supersaturation ratio compared to the thermodynamic solubility using the µDISS Profiler. The physically aged indapamide and metolazone and the minimally crystallized glibenclamide and hydrocortisone did not show significant differences in their C(max,app) and AUC when compared to the freshly spray-dried samples. Ketoconazole, with a crystalline content of 23%, reduced its C(max,app) and AUC by 50%, with C(max,app) being the same as the crystalline solubility. The AUC of aged metolazone, one of the two compounds that remained completely amorphous after storage, significantly improved as the crystallization kinetics significantly decreased. Glibenclamide improved the most in its supersaturation potential from amorphization. The study also revealed that, besides solid-state crystallization during storage, crystallization during dissolution and its corresponding pathway may significantly compromise the supersaturation potential of fully amorphous APIs.
format Online
Article
Text
id pubmed-6696415
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66964152019-09-05 Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage Edueng, Khadijah Mahlin, Denny Gråsjö, Johan Nylander, Olivia Thakrani, Manish Bergström, Christel A.S. Molecules Article This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoconazole, and sulfathiazole were used as model APIs. The parameters used to assess the supersaturation potential and crystallization kinetics were the maximum supersaturation concentration (C(max,app)), the area under the curve (AUC), and the crystallization rate constant (k). These were compared for freshly spray-dried and aged/crystallized samples. Aged samples were stored at 75% relative humidity for 168 days (6 months) or until they were completely crystallized, whichever came first. The solid-state changes were monitored with differential scanning calorimetry, Raman spectroscopy, and powder X-ray diffraction. Supersaturation potential and crystallization kinetics were investigated using a tenfold supersaturation ratio compared to the thermodynamic solubility using the µDISS Profiler. The physically aged indapamide and metolazone and the minimally crystallized glibenclamide and hydrocortisone did not show significant differences in their C(max,app) and AUC when compared to the freshly spray-dried samples. Ketoconazole, with a crystalline content of 23%, reduced its C(max,app) and AUC by 50%, with C(max,app) being the same as the crystalline solubility. The AUC of aged metolazone, one of the two compounds that remained completely amorphous after storage, significantly improved as the crystallization kinetics significantly decreased. Glibenclamide improved the most in its supersaturation potential from amorphization. The study also revealed that, besides solid-state crystallization during storage, crystallization during dissolution and its corresponding pathway may significantly compromise the supersaturation potential of fully amorphous APIs. MDPI 2019-07-27 /pmc/articles/PMC6696415/ /pubmed/31357587 http://dx.doi.org/10.3390/molecules24152731 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Edueng, Khadijah
Mahlin, Denny
Gråsjö, Johan
Nylander, Olivia
Thakrani, Manish
Bergström, Christel A.S.
Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
title Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
title_full Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
title_fullStr Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
title_full_unstemmed Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
title_short Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
title_sort supersaturation potential of amorphous active pharmaceutical ingredients after long-term storage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696415/
https://www.ncbi.nlm.nih.gov/pubmed/31357587
http://dx.doi.org/10.3390/molecules24152731
work_keys_str_mv AT eduengkhadijah supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage
AT mahlindenny supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage
AT grasjojohan supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage
AT nylanderolivia supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage
AT thakranimanish supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage
AT bergstromchristelas supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage